Hadron Energy (HDRN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
5 Oct, 2026Executive summary
The SPAC reported no operating revenue or operations in FY2025; results primarily reflected interest income on IPO proceeds held in trust and public-company expenses.
The proposed business combination with an early-stage microreactor developer remains subject to shareholder approval, minimum-cash and listing conditions, with a May 30, 2026 deadline to complete a combination.
The target developer reported no revenue, a $55.4M FY2025 net loss and substantial doubt about its ability to continue as a going concern.
Financial highlights
SPAC FY2025 net income was $3.83M, versus $2.38M from inception on May 8, 2024 through Dec. 31, 2024; FY2025 included $8.45M trust interest and $1.28M warrant fair-value expense.
FY2025 SPAC operating expenses were $3.34M; operating loss was $3.34M, offset by interest and dividend income and partially reduced by the warrant fair-value expense.
At Dec. 31, 2025, SPAC trust assets were $211.64M, outside-trust cash was $89,362, and working capital deficit was $1.88M.
Target developer FY2025 net loss was $55.43M, operating cash outflow was $3.86M, cash was $1.76M, and stockholders’ deficit was $56.02M; revenue was $0.
Outlook and guidance
The target developer expects significant expenses, capital spending and negative cash flows as it develops the Hadron Halo, pursues NRC approvals and prepares manufacturing; meaningful revenue depends on commercialization.
Initial deployment depends on regulatory approval and binding customer supply agreements; existing customer letters of intent are non-binding and contingent on approvals and testing.
Closing requires at least $20M in cash and $5,000,001 in net tangible assets, subject to the agreement’s terms; significant redemptions may increase financing needs and dilution.
Latest events from Hadron Energy
- Higher costs cut Q1 net income; merger closing hinges on cash, approvals and redemptions.HDRN
Q1 2026 - A $250 million blind-pool IPO pairs a 21-month deadline with steep dilution and conflicts.HDRN
Registration filing - A $250 million SPAC raise pairs a 24-month acquisition search with substantial dilution and conflicts.HDRN
Registration filing - IPO proceeds reached $200.0 million; a business-combination target remains unselected.HDRN
Q3 2024 - Trust interest lifted Q1 profit as target search and going-concern risks persist.HDRN
Q1 2025 - 25M-unit IPO filing amended solely to add exhibits, with a 3.75M-unit option.HDRN
Registration filing - Trust income drove earnings, but no target and limited operating cash sustain execution risk.HDRN
Q2 2025 - $250M SPAC, no target selected, 24-month deadline and material dilution risks.HDRN
Registration filing - A microreactor commercialization plan meets a large resale overhang and acute funding risk.HDRN
Registration filing